Proteomics

Dataset Information

0

Lung Cancer Drug resistance LC-MS/MS


ABSTRACT: In depth label free quantitative mass spectrometry based proteomics for identification of potential biomarkers of drug resistance in lung cancer.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung

SUBMITTER: Esen Efeoglu  

LAB HEAD: Paula Meleady

PROVIDER: PXD036996 | Pride | 2023-03-10

REPOSITORIES: Pride

altmetric image

Publications

Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells.

Efeoglu Esen E   Henry Michael M   Clynes Martin M   Meleady Paula P  

Biomolecules 20221001 10


The development of drug resistance in lung cancer is a major clinical challenge, leading to a 5-year survival rate of only 18%. Therefore, unravelling the mechanisms of drug resistance and developing novel therapeutic strategies is of crucial importance. This study systematically explores the novel biomarkers of drug resistance using a lung cancer model (DLKP) with a series of drug-resistant variants. In-depth label-free quantitative mass spectrometry-based proteomics and gene ontology analysis  ...[more]

Similar Datasets

2010-04-02 | E-GEOD-20749 | biostudies-arrayexpress
2009-10-23 | E-GEOD-17804 | biostudies-arrayexpress
2014-07-17 | E-GEOD-58637 | biostudies-arrayexpress
2022-06-09 | PXD027778 | Pride
2022-10-12 | PXD030771 | Pride
2020-01-21 | PXD016034 | Pride
2014-06-30 | E-GEOD-54072 | biostudies-arrayexpress
2024-09-02 | PXD052675 | Pride
2022-10-17 | PXD034568 | Pride
2014-07-18 | E-GEOD-58806 | biostudies-arrayexpress